Coya Therapeutics, Inc. (NASDAQ: COYA) reported Q2 EPS of ($0.19), $0.42 worse than the analyst estimate of $0.23. Revenue for the quarter came in at $3.43 million.

For earnings history and earnings-related data on Coya Therapeutics, Inc. (COYA) click here.